Addition of Phytosterols to a Low Phytosterol Diet

NCT ID: NCT00860054

Last Updated: 2012-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies have shown that phytosterols will lower LDL cholesterol. Typical diets can contain between 250 to 500 mg of naturally-occurring phytosterols. Long-term studies with phytosterol-containing products(such as margarines) have not taken into account the amounts of naturally occurring phytosterols in the diet. This means that the effects of small amounts of natural dietary phytosterols on LDL cholesterol are not known. In this study, we will examine the effects of phytosterols across a range of levels. The information will likely be used to further support and possibly extend the current dietary recommendations for phytosterol use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia Coronary Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Medium Phytosterols

Diets with daily 400 mg of phytosterols

Group Type EXPERIMENTAL

Different amount of phytosterols are added into diets

Intervention Type DIETARY_SUPPLEMENT

Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.

High Phytosterols Diet

Diet with 2000 mg of daily phytosterols

Group Type EXPERIMENTAL

Different amount of phytosterols are added into diets

Intervention Type DIETARY_SUPPLEMENT

Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.

Low Phyto Diet

Diet with less than 100 mg of daily phytosterols

Group Type PLACEBO_COMPARATOR

Different amount of phytosterols are added into diets

Intervention Type DIETARY_SUPPLEMENT

Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Different amount of phytosterols are added into diets

Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Men and women are eligible who:

* are of any race or ethnicity between 18 to 80 years of age;
* are in generally good health;
* have moderately elevated blood cholesterol(LDL cholesterol between 100 and 189 mg/dl)
* will eat only the foods that are provided by the center during the diet periods;
* will drink no more than 5 cups of caffeine-containing beverages a day;
* will consume no more than 1 alcoholic drink a day;
* will abstain from the consumption of alcohol for 48-hours prior to blood draw days

Exclusion Criteria

* are younger than 18 or older than 80 years;
* have very high cholesterol(LDL cholesterol equal to or above 190 mg/dl or triglycerides equal to or above 250 mg/dl);
* have very high blood pressure(equal to or above 160 mm Hg systolic or 95 mm Hg diastolic);
* are overweight( BMI greater than 35 kg/m2)
* are taking lipid-lowering, or any other medication known to affect blood cholesterol;
* have diabetes mellitus, cancer, heart, liver and/or kidney disease, or chronic disease that might interfere with participation;
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pennington Biomedical Research Center

OTHER

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Richard E. Ostlund Jr., MD

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard Ostlund, MD

Role: PRINCIPAL_INVESTIGATOR

Washington University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Racette SB, Lin X, Lefevre M, Spearie CA, Most MM, Ma L, Ostlund RE Jr. Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study. Am J Clin Nutr. 2010 Jan;91(1):32-8. doi: 10.3945/ajcn.2009.28070. Epub 2009 Nov 4.

Reference Type RESULT
PMID: 19889819 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HL050420

Identifier Type: NIH

Identifier Source: secondary_id

View Link

PBRC25025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

GPR146 and Cholesterol Metabolism
NCT07142317 NOT_YET_RECRUITING NA